Skip to main content
. Author manuscript; available in PMC: 2015 Jul 9.
Published in final edited form as: Cancer Prev Res (Phila). 2013 Dec 9;7(2):199–210. doi: 10.1158/1940-6207.CAPR-13-0181

Figure 4.

Figure 4

Metformin inhibits growth and RTK signaling of ErbB2– overexpressing breast cancer cells in vitro. A, effect of metformin on the proliferation of the selected cell lines. MCF-10A, BT-474, 78617, and SK-BR-3 cells were treated with metformin at indicated concentrations for 6 days, followed by SRB assay. B, Western blot analysis of RTK expression, activation, and signaling in ErbB2–overexpressing breast cancer cells.